{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T21:30:47Z","timestamp":1788903047353,"version":"build-2803163510"},"reference-count":248,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Western Pacific"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.lanwpc.2025.101684","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T04:06:32Z","timestamp":1758081992000},"page":"101684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Pan-Asian consortium for treatment and research in ALS (PACTALS) guidelines for management of amyotrophic lateral sclerosis"],"prefix":"10.1016","volume":"62","author":[{"given":"Steve","family":"Vucic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nortina","family":"Shahrizaila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Kano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvathi","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"Agustini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7868-1385","authenticated-orcid":false,"given":"Kongkiat","family":"Kulkantrakorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nalini","family":"Atchayaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0102-164X","authenticated-orcid":false,"given":"Yi-Chung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0465-0943","authenticated-orcid":false,"suffix":"Jr.","given":"Mario B.","family":"Prado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay W.P.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josiah","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bugyeong","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Talman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0054-7212","authenticated-orcid":false,"given":"Hoang Tien Trong","family":"Nghia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le Tu Quoc","family":"Tuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumoto","family":"Shibuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuishin","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Atsuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingsheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ohnmar","family":"Ohnmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remli","family":"Rabani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3325-6358","authenticated-orcid":false,"given":"Yoon-Ho","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Joon","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veena","family":"Raykar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kuwabara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gen","family":"Sobue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C.","family":"Kiernan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.lanwpc.2025.101684_bib1","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1136\/jnnp-2015-312751","article-title":"Amyotrophic lateral sclerosis and motor neuron syndromes in Asia","volume":"87","author":"Shahrizaila","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.lanwpc.2025.101684_bib2","article-title":"European Academy of Neurology (EAN) guideline on the management of amyotrophic lateral sclerosis in collaboration with European Reference Network for Neuromuscular Diseases (ERN EURO-NMD)","volume":"31","author":"Van Damme","year":"2024","journal-title":"Eur J Neurol"},{"issue":"15","key":"10.1016\/j.lanwpc.2025.101684_bib3","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1212\/WNL.0b013e3181bc01a4","volume":"73","author":"Miller","year":"2009","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.lanwpc.2025.101684_bib4","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1468-1331.2005.01351.x","article-title":"EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives","volume":"12","author":"Andersen","year":"2005","journal-title":"Eur J Neurol"},{"issue":"4","key":"10.1016\/j.lanwpc.2025.101684_bib5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/17482960701262376","article-title":"Good practice in the management of amyotrophic lateral sclerosis: clinical guidelines. An evidence-based review with good practice points. EALSC working group","volume":"8","author":"Andersen","year":"2007","journal-title":"Amyotroph Lateral Scler"},{"issue":"3","key":"10.1016\/j.lanwpc.2025.101684_bib6","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1468-1331.2011.03501.x","article-title":"EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force","volume":"19","author":"Andersen","year":"2012","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.lanwpc.2025.101684_bib7","series-title":"Motor neurone disease: assessment and management","year":"2016"},{"issue":"4","key":"10.1016\/j.lanwpc.2025.101684_bib8","doi-asserted-by":"crossref","first-page":"252","DOI":"10.5692\/clinicalneurol.cn-001946","article-title":"The clinical practice guideline for the management of amyotrophic lateral sclerosis in Japan-update 2023","volume":"64","author":"Urushitani","year":"2024","journal-title":"Rinsho Shinkeigaku"},{"issue":"9769","key":"10.1016\/j.lanwpc.2025.101684_bib9","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Kiernan","year":"2011","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.lanwpc.2025.101684_bib10","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJMra1603471","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Brown","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanwpc.2025.101684_bib11","article-title":"Amyotrophic lateral sclerosis","volume":"3","author":"Hardiman","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.lanwpc.2025.101684_bib12","article-title":"Riluzole for amyotrophic lateral sclerosis (ALS)\/Motor neuron disease (MND)","volume":"3","author":"Miller","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.lanwpc.2025.101684_bib13","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.cell.2017.10.011","article-title":"Edaravone: a new drug approved for ALS","volume":"171","author":"Rothstein","year":"2017","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.lanwpc.2025.101684_bib14","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJMoa1916945","article-title":"Trial of sodium phenylbutyrate-taurursodiol for amyotrophic lateral sclerosis","volume":"383","author":"Paganoni","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.lanwpc.2025.101684_bib15","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/jamaneurol.2022.0901","article-title":"Efficacy and safety of ultrahigh-dose methylcobalamin in early-stage amyotrophic lateral sclerosis: a randomized clinical trial","volume":"79","author":"Oki","year":"2022","journal-title":"JAMA Neurol"},{"issue":"2","key":"10.1016\/j.lanwpc.2025.101684_bib16","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/med.21528","article-title":"Riluzole and edaravone: a tale of two amyotrophic lateral sclerosis drugs","volume":"39","author":"Jaiswal","year":"2019","journal-title":"Med Res Rev"},{"issue":"6","key":"10.1016\/j.lanwpc.2025.101684_bib17","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2217\/nmt-2020-0033","article-title":"Riluzole for the treatment of amyotrophic lateral sclerosis","volume":"10","author":"Saitoh","year":"2020","journal-title":"Neurodegener Dis Manag"},{"issue":"2","key":"10.1016\/j.lanwpc.2025.101684_bib18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/jamaneurol.2021.4893","article-title":"Safety and effectiveness of long-term intravenous administration of edaravone for treatment of patients with amyotrophic lateral sclerosis","volume":"79","author":"Witzel","year":"2022","journal-title":"JAMA Neurol"},{"issue":"3","key":"10.1016\/j.lanwpc.2025.101684_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd9036","article-title":"Genetic analysis of amyotrophic lateral sclerosis identifies contributing pathways and cell types","volume":"7","author":"Saez-Atienzar","year":"2021","journal-title":"Sci Adv"},{"issue":"3","key":"10.1016\/j.lanwpc.2025.101684_bib20","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41573-022-00612-2","article-title":"Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation","volume":"22","author":"Mead","year":"2023","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"10.1016\/j.lanwpc.2025.101684_bib21","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s40263-021-00820-1","article-title":"Pathophysiology and treatment of non-motor dysfunction in amyotrophic lateral sclerosis","volume":"35","author":"Mahoney","year":"2021","journal-title":"CNS Drugs"},{"issue":"8","key":"10.1016\/j.lanwpc.2025.101684_bib22","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.tins.2014.05.006","article-title":"Advances in treating amyotrophic lateral sclerosis: insights from pathophysiological studies","volume":"37","author":"Vucic","year":"2014","journal-title":"Trends Neurosci"},{"issue":"5","key":"10.1016\/j.lanwpc.2025.101684_bib23","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S1474-4422(21)00465-8","article-title":"Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis","volume":"21","author":"Goutman","year":"2022","journal-title":"Lancet Neurol"},{"issue":"10360","key":"10.1016\/j.lanwpc.2025.101684_bib24","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","article-title":"Amyotrophic lateral sclerosis","volume":"400","author":"Feldman","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.lanwpc.2025.101684_bib25","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.clinph.2020.04.005","article-title":"A proposal for new diagnostic criteria for ALS","volume":"131","author":"Shefner","year":"2020","journal-title":"Clin Neurophysiol"},{"issue":"4","key":"10.1016\/j.lanwpc.2025.101684_bib26","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","article-title":"GRADE guidelines: a new series of articles in the journal of clinical epidemiology","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.lanwpc.2025.101684_bib27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jclinepi.2016.09.009","article-title":"GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT","volume":"81","author":"Sch\u00fcnemann","year":"2017","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.lanwpc.2025.101684_bib28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jclinepi.2018.09.007","article-title":"Evidence to decision framework provides a structured \"roadmap\" for making GRADE guidelines recommendations","volume":"104","author":"Li","year":"2018","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.lanwpc.2025.101684_bib29","article-title":"Regional health priorities for dementia: a roadmap for the Western Pacific","volume":"50","author":"Timmins","year":"2024","journal-title":"Lancet Reg Health West Pac"},{"issue":"Suppl","key":"10.1016\/j.lanwpc.2025.101684_bib30","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0022-510X(94)90191-0","volume":"124","author":"Brooks","year":"1994","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.lanwpc.2025.101684_bib31","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/146608200300079536","article-title":"El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"1","author":"Brooks","year":"2000","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"issue":"1","key":"10.1016\/j.lanwpc.2025.101684_bib32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/146608299300079501","article-title":"Fibrillation and sharp-waves: do we need them to diagnose ALS?","volume":"1","author":"de Carvalho","year":"1999","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"issue":"3","key":"10.1016\/j.lanwpc.2025.101684_bib33","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.clinph.2007.09.143","article-title":"Electrodiagnostic criteria for diagnosis of ALS","volume":"119","author":"de Carvalho","year":"2008","journal-title":"Clin Neurophysiol"},{"issue":"11","key":"10.1016\/j.lanwpc.2025.101684_bib34","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1001\/archneurol.2012.254","article-title":"Awaji criteria for the diagnosis of amyotrophic lateral sclerosis:a systematic review","volume":"69","author":"Costa","year":"2012","journal-title":"Arch Neurol"},{"issue":"6","key":"10.1016\/j.lanwpc.2025.101684_bib35","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/mus.24575","article-title":"AWAJI criteria are not always superior to the previous criteria: a meta-analysis","volume":"51","author":"Jang","year":"2015","journal-title":"Muscle Nerve"},{"issue":"7","key":"10.1016\/j.lanwpc.2025.101684_bib36","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1016\/j.clinph.2016.04.005","article-title":"Awaji criteria improves the diagnostic sensitivity in amyotrophic lateral sclerosis: a systematic review using individual patient data","volume":"127","author":"Geevasinga","year":"2016","journal-title":"Clin Neurophysiol"},{"issue":"2","key":"10.1016\/j.lanwpc.2025.101684_bib37","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.clinph.2018.11.021","article-title":"Diagnostic criteria for amyotrophic lateral sclerosis: a multicentre study of inter-rater variation and sensitivity","volume":"130","author":"Johnsen","year":"2019","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.lanwpc.2025.101684_bib38","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1001\/archneur.57.8.1171","article-title":"Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie house diagnostic criteria: a population-based study","volume":"57","author":"Traynor","year":"2000","journal-title":"Arch Neurol"},{"issue":"11","key":"10.1016\/j.lanwpc.2025.101684_bib39","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3390\/brainsci14111055","article-title":"Gold Coast criteria in ALS diagnosis: a real-world experience","volume":"14","author":"Ferullo","year":"2024","journal-title":"Brain Sci"},{"issue":"8","key":"10.1016\/j.lanwpc.2025.101684_bib40","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/jnnp-2022-328823","article-title":"Characterising ALS disease progression according to El escorial and Gold Coast criteria","volume":"93","author":"de Jongh","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"10.1016\/j.lanwpc.2025.101684_bib41","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1016\/j.clinph.2021.08.014","article-title":"Gold Coast diagnostic criteria increase sensitivity in amyotrophic lateral sclerosis","volume":"132","author":"Pugdahl","year":"2021","journal-title":"Clin Neurophysiol"},{"issue":"4","key":"10.1016\/j.lanwpc.2025.101684_bib42","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/mus.27660","article-title":"Gold Coast criteria expand clinical trial eligibility in amyotrophic lateral sclerosis","volume":"66","author":"Jewett","year":"2022","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.lanwpc.2025.101684_bib43","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40035-021-00253-2","article-title":"The gold coast criteria increases the diagnostic sensitivity for amyotrophic lateral sclerosis in a Chinese population","volume":"10","author":"Shen","year":"2021","journal-title":"Transl Neurodegener"},{"issue":"3\u20134","key":"10.1016\/j.lanwpc.2025.101684_bib44","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/21678421.2024.2303062","article-title":"Diagnostic utility of gold coast criteria for amyotrophic lateral sclerosis in Asia","volume":"25","author":"Otani","year":"2024","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"5","key":"10.1016\/j.lanwpc.2025.101684_bib45","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/ana.26045","article-title":"Diagnostic utility of gold coast criteria in amyotrophic lateral sclerosis","volume":"89","author":"Hannaford","year":"2021","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.lanwpc.2025.101684_bib46","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/mus.27392","article-title":"Gold coast diagnostic criteria: implications for ALS diagnosis and clinical trial enrollment","volume":"64","author":"Vucic","year":"2021","journal-title":"Muscle Nerve"},{"issue":"12","key":"10.1016\/j.lanwpc.2025.101684_bib47","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1016\/j.clinph.2021.09.001","article-title":"Diagnostic criteria of ALS. Are the gold coast criteria the ultimate solution?","volume":"132","author":"Dengler","year":"2021","journal-title":"Clin Neurophysiol"},{"issue":"3","key":"10.1016\/j.lanwpc.2025.101684_bib48","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1136\/practneurol-2021-003256","article-title":"Diagnosing ALS: the gold coast criteria and the role of EMG","volume":"22","author":"Turner","year":"2022","journal-title":"Pract Neurol"},{"issue":"1","key":"10.1016\/j.lanwpc.2025.101684_bib49","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2024.2398199","article-title":"From suspicion to diagnosis: exploration strategy for suspected amyotrophic lateral sclerosis","volume":"56","author":"Garnier","year":"2024","journal-title":"Ann Med"},{"issue":"4","key":"10.1016\/j.lanwpc.2025.101684_bib50","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/14737175.2025.2471556","article-title":"Advances in the early diagnosis of amyotrophic lateral sclerosis","volume":"25","author":"Garc\u00eda-Casanova","year":"2025","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.lanwpc.2025.101684_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2025.123418","article-title":"Usefulness of the gold coast criteria in diagnosing fast-progressing amyotrophic lateral sclerosis","volume":"471","author":"Ohnari","year":"2025","journal-title":"J Neurol Sci"},{"issue":"5","key":"10.1016\/j.lanwpc.2025.101684_bib52","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/WCO.0000000000001302","article-title":"Diagnostic criteria for amyotrophic lateral sclerosis","volume":"37","author":"Timmins","year":"2024","journal-title":"Curr Opin Neurol"},{"issue":"6","key":"10.1016\/j.lanwpc.2025.101684_bib53","doi-asserted-by":"crossref","DOI":"10.1111\/ene.70203","article-title":"Utility of cortical inhibitory and facilitatory neuronal circuits in amyotrophic lateral sclerosis diagnosis","volume":"32","author":"Santos Silva","year":"2025","journal-title":"Eur J Neurol"},{"issue":"11","key":"10.1016\/j.lanwpc.2025.101684_bib54","first-page":"1217","article-title":"[Gold coast criteria: a new diagnostic paradigm in the era of disease-modifying therapy for amyotrophic lateral sclerosis]","volume":"76","author":"Yamakawa","year":"2024","journal-title":"Brain Nerve"},{"key":"10.1016\/j.lanwpc.2025.101684_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2025.123417","article-title":"Utility of the gold coast criteria for amyotrophic lateral sclerosis: experience with fast progressors","volume":"470","author":"Kiernan","year":"2025","journal-title":"J Neurol Sci"},{"issue":"5","key":"10.1016\/j.lanwpc.2025.101684_bib56","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/brain\/awt085","article-title":"Riluzole exerts central and peripheral modulating effects in amyotrophic lateral sclerosis","volume":"136","author":"Vucic","year":"2013","journal-title":"Brain"},{"issue":"7\u20138","key":"10.1016\/j.lanwpc.2025.101684_bib57","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1080\/21678421.2016.1188961","article-title":"Riluzole exerts transient modulating effects on cortical and axonal hyperexcitability in ALS","volume":"17","author":"Geevasinga","year":"2016","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"5","key":"10.1016\/j.lanwpc.2025.101684_bib58","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0959-4388(96)80103-6","article-title":"Therapeutic Horizons for amyotrophic lateral sclerosis","volume":"6","author":"Rothstein","year":"1996","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.lanwpc.2025.101684_bib59","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJM199403033300901","article-title":"A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS\/Riluzole Study Group","volume":"330","author":"Bensimon","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanwpc.2025.101684_bib60","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0140-6736(96)91680-3","article-title":"Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis\/Riluzole Study Group II","volume":"347","author":"Lacomblez","year":"1996","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.lanwpc.2025.101684_bib61","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s004150200071","article-title":"A study of riluzole in the treatment of advanced stage or elderly patients with amyotrophic lateral sclerosis","volume":"249","author":"Bensimon","year":"2002","journal-title":"J Neurol"},{"issue":"11","key":"10.1016\/j.lanwpc.2025.101684_bib62","first-page":"851","article-title":"Efficacy and safety of riluzole in patients with amyotrophic lateral sclerosis: double-blind placebo-controlled study in Japan","volume":"182","author":"Yanagisawa","year":"1997"},{"issue":"5","key":"10.1016\/j.lanwpc.2025.101684_bib63","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1474-4422(18)30054-1","article-title":"Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study","volume":"17","author":"Fang","year":"2018","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.lanwpc.2025.101684_bib64","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0022-3565(24)36676-5","article-title":"Effects of a novel free radical scavenger, MCI-186, on ischemic brain damage in the rat distal middle cerebral artery occlusion model","volume":"281","author":"Kawai","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"issue":"7\u20138","key":"10.1016\/j.lanwpc.2025.101684_bib65","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3109\/21678421.2014.959024","article-title":"Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients","volume":"15","author":"Abe","year":"2014","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"7","key":"10.1016\/j.lanwpc.2025.101684_bib66","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S1474-4422(17)30115-1","article-title":"Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial","volume":"16","year":"2017","journal-title":"Lancet Neurol"},{"issue":"sup1","key":"10.1016\/j.lanwpc.2025.101684_bib67","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/21678421.2017.1361441","article-title":"Exploratory double-blind, parallel-group, placebo-controlled study of edaravone (MCI-186) in amyotrophic lateral sclerosis (Japan ALS severity classification: grade 3, requiring assistance for eating, excretion or ambulation)","volume":"18","year":"2017","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"sup1","key":"10.1016\/j.lanwpc.2025.101684_bib68","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/21678421.2017.1364269","article-title":"Open-label 24-week extension study of edaravone (MCI-186) in amyotrophic lateral sclerosis","volume":"18","year":"2017","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"6","key":"10.1016\/j.lanwpc.2025.101684_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258614","article-title":"Edaravone efficacy in amyotrophic lateral sclerosis with reduced forced vital capacity: post-hoc analysis of study 19 (MCI186-19) [clinical trial NCT01492686]","volume":"17","author":"Brooks","year":"2022","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.lanwpc.2025.101684_bib70","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/mus.27467","article-title":"Slowing the loss of physical function in amyotrophic lateral sclerosis with edaravone: post hoc analysis of ALSFRS-R item scores in pivotal study MCI186-19","volume":"65","author":"Brooks","year":"2022","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.lanwpc.2025.101684_bib71","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10072-018-3653-2","article-title":"Efficacy and safety of edaravone in treatment of amyotrophic lateral sclerosis\u2014a systematic review and meta-analysis","volume":"40","author":"Luo","year":"2019","journal-title":"Neurol Sci"},{"issue":"1","key":"10.1016\/j.lanwpc.2025.101684_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40261-022-01229-4","article-title":"Safety and efficacy of edaravone in patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"43","author":"Gao","year":"2023","journal-title":"Clin Drug Investig"},{"issue":"10","key":"10.1016\/j.lanwpc.2025.101684_bib73","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1007\/s10072-023-06869-8","article-title":"Safety and efficacy of edaravone in patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"44","author":"Nourelden","year":"2023","journal-title":"Neurol Sci"},{"issue":"3","key":"10.1016\/j.lanwpc.2025.101684_bib74","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s13760-024-02476-2","article-title":"Edaravone for patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"124","author":"Huang","year":"2024","journal-title":"Acta Neurol Belg"},{"issue":"10","key":"10.1016\/j.lanwpc.2025.101684_bib75","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/cpdd.952","article-title":"Bioequivalence study of oral suspension and intravenous formulation of edaravone in healthy adult subjects","volume":"10","author":"Shimizu","year":"2021","journal-title":"Clin Pharmacol Drug Dev"},{"issue":"1","key":"10.1016\/j.lanwpc.2025.101684_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(93)90925-8","article-title":"Protective effects of a vitamin B12 analog, methylcobalamin, against glutamate cytotoxicity in cultured cortical neurons","volume":"241","author":"Akaike","year":"1993","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.lanwpc.2025.101684_bib77","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/0022-510X(94)90290-9","article-title":"Ultra-high dose methylcobalamin promotes nerve regeneration in experimental acrylamide neuropathy","volume":"122","author":"Watanabe","year":"1994","journal-title":"J Neurol Sci"},{"issue":"3","key":"10.1016\/j.lanwpc.2025.101684_bib78","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.taap.2011.01.003","article-title":"Methyl vitamin B12 but not methylfolate rescues a motor neuron-like cell line from homocysteine-mediated cell death","volume":"251","author":"Hemendinger","year":"2011","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"10.1016\/j.lanwpc.2025.101684_bib79","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.freeradbiomed.2009.04.023","article-title":"A novel role for vitamin B(12): cobalamins are intracellular antioxidants in vitro","volume":"47","author":"Birch","year":"2009","journal-title":"Free Radic Biol Med"},{"issue":"42","key":"10.1016\/j.lanwpc.2025.101684_bib80","doi-asserted-by":"crossref","first-page":"15078","DOI":"10.1021\/ja904670x","article-title":"Vitamin B(12) and redox homeostasis: cob(II)alamin reacts with superoxide at rates approaching superoxide dismutase (SOD)","volume":"131","author":"Suarez-Moreira","year":"2009","journal-title":"J Am Chem Soc"},{"issue":"4","key":"10.1016\/j.lanwpc.2025.101684_bib81","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1136\/jnnp-2018-319294","article-title":"Ultra-high-dose methylcobalamin in amyotrophic lateral sclerosis: a long-term phase II\/III randomised controlled study","volume":"90","author":"Kaji","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"10.1016\/j.lanwpc.2025.101684_bib82","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrneurol.2011.150","article-title":"Clinical genetics of amyotrophic lateral sclerosis: what do we really know?","volume":"7","author":"Andersen","year":"2011","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"10.1016\/j.lanwpc.2025.101684_bib83","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/jnnp-2016-315018","article-title":"Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"88","author":"Zou","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"15","key":"10.1016\/j.lanwpc.2025.101684_bib84","doi-asserted-by":"crossref","first-page":"e1657","DOI":"10.1212\/WNL.0000000000009015","article-title":"ALS is a multistep process in South Korean, Japanese, and Australian patients","volume":"94","author":"Vucic","year":"2020","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.lanwpc.2025.101684_bib85","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/brain\/awab472","article-title":"The importance of offering early genetic testing in everyone with amyotrophic lateral sclerosis","volume":"145","author":"Salmon","year":"2022","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.lanwpc.2025.101684_bib86","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1172\/JCI99081","article-title":"Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models","volume":"128","author":"McCampbell","year":"2018","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.lanwpc.2025.101684_bib87","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrneurol.2017.148","article-title":"Antisense oligonucleotides: the next frontier for treatment of neurological disorders","volume":"14","author":"Rinaldi","year":"2018","journal-title":"Nat Rev Neurol"},{"issue":"17","key":"10.1016\/j.lanwpc.2025.101684_bib88","doi-asserted-by":"crossref","first-page":"17181","DOI":"10.1074\/jbc.M311683200","article-title":"Determination of the role of the human RNase H1 in the pharmacology of DNA-like antisense drugs","volume":"279","author":"Wu","year":"2004","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.lanwpc.2025.101684_bib89","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJMoa2204705","article-title":"Trial of antisense oligonucleotide tofersen for SOD1 ALS","volume":"387","author":"Miller","year":"2022","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.lanwpc.2025.101684_bib90","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/mus.28182","article-title":"Clinical and patient-reported outcomes and neurofilament response during tofersen treatment in SOD1-related ALS-A multicenter observational study over 18 months","volume":"70","author":"Meyer","year":"2024","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.lanwpc.2025.101684_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102495","article-title":"Effects of tofersen treatment in patients with SOD1-ALS in a \"real-world\" setting - a 12-month multicenter cohort study from the German early access program","volume":"69","author":"Wiesenfarth","year":"2024","journal-title":"eClinicalMedicine"},{"issue":"1","key":"10.1016\/j.lanwpc.2025.101684_bib92","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s43856-024-00573-0","article-title":"Tofersen decreases neurofilament levels supporting the pathogenesis of the SOD1 p.D91A variant in amyotrophic lateral sclerosis patients","volume":"4","author":"Weishaupt","year":"2024","journal-title":"Commun Med"},{"issue":"8","key":"10.1016\/j.lanwpc.2025.101684_bib93","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.1007\/s00415-024-12437-7","article-title":"Long-term treatment of SOD1 ALS with tofersen: a multicentre experience in 17 patients","volume":"271","author":"Sabatelli","year":"2024","journal-title":"J Neurol"},{"issue":"2","key":"10.1016\/j.lanwpc.2025.101684_bib94","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/acn3.52264","article-title":"Tofersen treatment leads to sustained stabilization of disease in SOD1 ALS in a \"real-world\" setting","volume":"12","author":"Smith","year":"2025","journal-title":"Ann Clin Transl Neurol"},{"issue":"4","key":"10.1016\/j.lanwpc.2025.101684_bib95","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/jdn.10101","article-title":"Stem cell in neurodegenerative disorders; an emerging strategy","volume":"81","author":"Ahani-Nahayati","year":"2021","journal-title":"Int J Dev Neurosci"},{"issue":"4","key":"10.1016\/j.lanwpc.2025.101684_bib96","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1212\/WNL.0000000000002906","article-title":"Stem cells in amyotrophic lateral sclerosis: ready for prime time?","volume":"87","author":"Appel","year":"2016","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.lanwpc.2025.101684_bib97","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.5966\/sctm.2015-0217","article-title":"Mesenchymal stem cells modulate the functional properties of microglia via TGF-\u03b2 secretion","volume":"5","author":"Noh","year":"2016","journal-title":"Stem Cells Transl Med"},{"issue":"4","key":"10.1016\/j.lanwpc.2025.101684_bib98","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/stcltm\/szad095","article-title":"Optimal therapeutic strategy of bone marrow-originated autologous mesenchymal stromal\/stem cells for ALS","volume":"13","author":"Kim","year":"2024","journal-title":"Stem Cells Transl Med"},{"issue":"3","key":"10.1016\/j.lanwpc.2025.101684_bib99","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/ana.25302","article-title":"Repeated intrathecal mesenchymal stem cells for amyotrophic lateral sclerosis","volume":"84","author":"Oh","year":"2018","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.lanwpc.2025.101684_bib100","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/jnc.12814","article-title":"The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients","volume":"131","author":"Kwon","year":"2014","journal-title":"J Neurochem"},{"issue":"12","key":"10.1016\/j.lanwpc.2025.101684_bib101","first-page":"Cd011742","article-title":"Cell-based therapies for amyotrophic lateral sclerosis\/motor neuron disease","volume":"12","author":"Abdul Wahid","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.lanwpc.2025.101684_bib102","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3988\/jcn.2015.11.2.164","article-title":"Granulocyte colony-stimulating factor for amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled study of Iranian patients","volume":"11","author":"Amirzagar","year":"2015","journal-title":"J Clin Neurol"},{"issue":"2","key":"10.1016\/j.lanwpc.2025.101684_bib103","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/mus.21851","article-title":"Repeated courses of granulocyte colony-stimulating factor in amyotrophic lateral sclerosis: clinical and biological results from a prospective multicenter study","volume":"43","author":"Chi\u00f2","year":"2011","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.lanwpc.2025.101684_bib104","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017770","article-title":"G-CSF prevents the progression of structural disintegration of white matter tracts in amyotrophic lateral sclerosis: a pilot trial","volume":"6","author":"Duning","year":"2011","journal-title":"PLoS One"},{"issue":"1\u20132","key":"10.1016\/j.lanwpc.2025.101684_bib105","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/17482960902933809","article-title":"Recombinant human granulocyte-colony stimulating factor administration for treating amyotrophic lateral sclerosis: a pilot study","volume":"11","author":"Nefussy","year":"2010","journal-title":"Amyotroph Lateral Scler"},{"issue":"24","key":"10.1016\/j.lanwpc.2025.101684_bib106","doi-asserted-by":"crossref","first-page":"e2294","DOI":"10.1212\/WNL.0000000000008620","article-title":"NurOwn, phase 2, randomized, clinical trial in patients with ALS: safety, clinical, and biomarker results","volume":"93","author":"Berry","year":"2019","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.lanwpc.2025.101684_bib107","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/mus.27472","article-title":"A randomized placebo-controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosis","volume":"65","author":"Cudkowicz","year":"2022","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.lanwpc.2025.101684_bib108","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1148444","article-title":"Long-term survival benefits of intrathecal autologous bone marrow-derived mesenchymal stem cells (Neuronata-R\u00ae: lenzumestrocel) treatment in ALS: propensity-Score-Matched control, surveillance study","volume":"15","author":"Nam","year":"2023","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.lanwpc.2025.101684_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102036","article-title":"Efficacy and safety of CNM-Au8 in amyotrophic lateral sclerosis (RESCUE-ALS study): a phase 2, randomised, double-blind, placebo-controlled trial and open label extension","volume":"60","author":"Vucic","year":"2023","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.lanwpc.2025.101684_bib110","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/jnnp.74.9.1258","article-title":"Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000","volume":"74","author":"Traynor","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.lanwpc.2025.101684_bib111","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/17482968.2012.690419","article-title":"The natural history of motor neuron disease: assessing the impact of specialist care","volume":"14","author":"Aridegbe","year":"2013","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"5","key":"10.1016\/j.lanwpc.2025.101684_bib112","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/jnnp-2014-309601","article-title":"A multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and northern Ireland","volume":"86","author":"Rooney","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7\u20138","key":"10.1016\/j.lanwpc.2025.101684_bib113","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/21678421.2017.1349151","article-title":"The benefit of evolving multidisciplinary care in ALS: a diagnostic cohort survival comparison","volume":"18","author":"Martin","year":"2017","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"327","key":"10.1016\/j.lanwpc.2025.101684_bib114","first-page":"2","article-title":"Multidisciplinary care improves survival of patients with amyotrophic lateral sclerosis in the unique health system (Sus) in Brazil","volume":"5","author":"Moura","year":"2017"},{"issue":"Suppl 5","key":"10.1016\/j.lanwpc.2025.101684_bib115","first-page":"56","article-title":"[The patient's opinion matters: experience in the nutritional care in an ALS multidisciplinary team]","volume":"31","author":"Jim\u00e9nez Garc\u00eda","year":"2015","journal-title":"Nutr Hosp"},{"key":"10.1016\/j.lanwpc.2025.101684_bib116","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2147\/JMDH.S205313","article-title":"Survival benefit of multidisciplinary care in amyotrophic lateral sclerosis in Spain: association with noninvasive mechanical ventilation","volume":"12","author":"Paipa","year":"2019","journal-title":"J Multidiscip Healthc"},{"issue":"3\u20134","key":"10.1016\/j.lanwpc.2025.101684_bib117","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/21678421.2014.994530","article-title":"Multidisciplinary ALS clinics in the USA: a comparison of those who attend and those who do not","volume":"16","author":"Stephens","year":"2015","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"8","key":"10.1016\/j.lanwpc.2025.101684_bib118","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1212\/01.wnl.0000180717.29273.12","article-title":"Multidisciplinary ALS care improves quality of life in patients with ALS","volume":"65","author":"Van den Berg","year":"2005","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.lanwpc.2025.101684_bib119","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1136\/jnnp.2005.083402","article-title":"Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities","volume":"77","author":"Chi\u00f2","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.lanwpc.2025.101684_bib120","first-page":"Cd007425","article-title":"Multidisciplinary care for adults with amyotrophic lateral sclerosis or motor neuron disease","volume":"7","author":"Ng","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.lanwpc.2025.101684_bib121","article-title":"Symptomatic treatments for amyotrophic lateral sclerosis\/motor neuron disease","volume":"1","author":"Ng","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.lanwpc.2025.101684_bib122","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s10072-020-05011-2","article-title":"Multidisciplinary care in amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"42","author":"de Almeida","year":"2021","journal-title":"Neurol Sci"},{"issue":"8","key":"10.1016\/j.lanwpc.2025.101684_bib123","doi-asserted-by":"crossref","first-page":"357","DOI":"10.5694\/mja16.01063","article-title":"Motor neurone disease: progress and challenges","volume":"206","author":"Dharmadasa","year":"2017","journal-title":"Med J Aust"},{"key":"10.1016\/j.lanwpc.2025.101684_bib124","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jocn.2022.10.011","article-title":"Multidisciplinary clinic contributes to the decreasing trend in the number of emergency hospitalizations for amyotrophic lateral sclerosis in Japan","volume":"107","author":"Sugisawa","year":"2023","journal-title":"J Clin Neurosci"},{"issue":"5\u20136","key":"10.1016\/j.lanwpc.2025.101684_bib125","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/21678421.2021.1980889","article-title":"MiNDAUS partnership: a roadmap for the cure and management of motor Neurone disease","volume":"23","author":"Vucic","year":"2022","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"9","key":"10.1016\/j.lanwpc.2025.101684_bib126","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012054","article-title":"Identification and outcomes of clinical phenotypes in amyotrophic lateral sclerosis\/motor neuron disease: Australian national motor neuron disease observational cohort","volume":"6","author":"Talman","year":"2016","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.lanwpc.2025.101684_bib127","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S1474-4422(18)30089-9","article-title":"Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model","volume":"17","author":"Westeneng","year":"2018","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.lanwpc.2025.101684_bib128","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S1474-4422(05)70326-4","article-title":"Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial","volume":"5","author":"Bourke","year":"2006","journal-title":"Lancet Neurol"},{"issue":"10","key":"10.1016\/j.lanwpc.2025.101684_bib129","article-title":"Mechanical ventilation for amyotrophic lateral sclerosis\/motor neuron disease","volume":"10","author":"Radunovic","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.lanwpc.2025.101684_bib130","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004427.pub3","article-title":"Mechanical ventilation for amyotrophic lateral sclerosis\/motor neuron disease","volume":"28","author":"Radunovic","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.lanwpc.2025.101684_bib131","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/jnnp-2014-310055","article-title":"Identifying who will benefit from non-invasive ventilation in amyotrophic lateral sclerosis\/motor neurone disease in a clinical cohort","volume":"87","author":"Berlowitz","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.lanwpc.2025.101684_bib132","doi-asserted-by":"crossref","DOI":"10.1590\/1516-3180.2022.0470.r1.100423","article-title":"Noninvasive mechanical ventilation assistance in amyotrophic lateral sclerosis: a systematic review","volume":"142","author":"Cunha-Correia","year":"2023","journal-title":"Sao Paulo Med J"},{"issue":"1","key":"10.1016\/j.lanwpc.2025.101684_bib133","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12904-024-01429-z","article-title":"Optimizing breathlessness management in amyotrophic lateral sclerosis: insights from a comprehensive systematic review","volume":"23","author":"Filipe","year":"2024","journal-title":"BMC Palliat Care"},{"issue":"7\u20138","key":"10.1016\/j.lanwpc.2025.101684_bib134","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1080\/21678421.2021.1904993","article-title":"Noninvasive ventilation use by patients enrolled in VITALITY-ALS","volume":"22","author":"Rudnicki","year":"2021","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"3","key":"10.1016\/j.lanwpc.2025.101684_bib135","doi-asserted-by":"crossref","first-page":"1900261","DOI":"10.1183\/13993003.00261-2019","article-title":"The optimisation of noninvasive ventilation in amyotrophic lateral sclerosis: a systematic review","volume":"54","author":"O'Brien","year":"2019","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.lanwpc.2025.101684_bib136","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3233\/JND-221658","article-title":"Impact of early non-invasive ventilation in amyotrophic lateral sclerosis: a multicenter randomized controlled trial","volume":"10","author":"Sarasate","year":"2023","journal-title":"J Neuromuscul Dis"},{"issue":"18","key":"10.1016\/j.lanwpc.2025.101684_bib137","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1212\/WNL.0000000000003158","article-title":"Trial of early noninvasive ventilation for ALS: a pilot placebo-controlled study","volume":"87","author":"Jacobs","year":"2016","journal-title":"Neurology"},{"issue":"7\u20138","key":"10.1016\/j.lanwpc.2025.101684_bib138","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/21678421.2019.1627372","article-title":"Optimizing the noninvasive ventilation pathway for patients with amyotrophic lateral sclerosis\/motor neuron disease: a systematic review","volume":"20","author":"Baxter","year":"2019","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"15","key":"10.1016\/j.lanwpc.2025.101684_bib139","doi-asserted-by":"crossref","first-page":"e1634","DOI":"10.1212\/WNL.0000000000206830","article-title":"Respiratory strength training in amyotrophic lateral sclerosis: a double-blind, randomized, multicenter, sham-controlled trial","volume":"100","author":"Plowman","year":"2023","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.lanwpc.2025.101684_bib140","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S1474-4422(16)30233-2","article-title":"Early diaphragm pacing in patients with amyotrophic lateral sclerosis (RespiStimALS): a randomised controlled triple-blind trial","volume":"15","author":"Gonzalez-Bermejo","year":"2016","journal-title":"Lancet Neurol"},{"issue":"45","key":"10.1016\/j.lanwpc.2025.101684_bib141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta20450","article-title":"DiPALS: Diaphragm pacing in patients with amyotrophic lateral sclerosis - a randomised controlled trial","volume":"20","author":"McDermott","year":"2016","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.lanwpc.2025.101684_bib142","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2013.13830","article-title":"Is tracheostomy still an option in amyotrophic lateral sclerosis? Reflections of a multidisciplinary work group","volume":"143","author":"Heritier Barras","year":"2013","journal-title":"Swiss Med Wkly"},{"issue":"2","key":"10.1016\/j.lanwpc.2025.101684_bib143","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2217\/nmt-2015-0010","article-title":"Practical respiratory management in amyotrophic lateral sclerosis: evidence, controversies and recent advances","volume":"6","author":"Bourke","year":"2016","journal-title":"Neurodegener Dis Manag"},{"issue":"1\u20132","key":"10.1016\/j.lanwpc.2025.101684_bib144","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jns.2014.06.047","article-title":"Tracheostomy and invasive ventilation in Japanese ALS patients: decision-making and survival analysis: 1990-2010","volume":"344","author":"Tagami","year":"2014","journal-title":"J Neurol Sci"},{"issue":"4","key":"10.1016\/j.lanwpc.2025.101684_bib145","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/ene.14647","article-title":"Non-invasive and tracheostomy invasive ventilation in amyotrophic lateral sclerosis: utilization and survival rates in a cohort study over 12 years in Germany","volume":"28","author":"Spittel","year":"2021","journal-title":"Eur J Neurol"},{"issue":"5","key":"10.1016\/j.lanwpc.2025.101684_bib146","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.neurol.2017.03.032","article-title":"Ethical considerations and palliative care in patients with amyotrophic lateral sclerosis: a review","volume":"173","author":"Danel-Brunaud","year":"2017","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.lanwpc.2025.101684_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2022.106740","article-title":"The use of cough peak flow in the assessment of respiratory function in clinical practice- a narrative literature review","volume":"193","author":"Brennan","year":"2022","journal-title":"Respir Med"},{"issue":"6","key":"10.1016\/j.lanwpc.2025.101684_bib148","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1136\/jnnp.2010.211474","article-title":"Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients","volume":"82","author":"Marin","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lanwpc.2025.101684_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.117257","article-title":"Hypermetabolism is a reality in amyotrophic lateral sclerosis compared to healthy subjects","volume":"420","author":"Fayemendy","year":"2021","journal-title":"J Neurol Sci"},{"issue":"sup1","key":"10.1016\/j.lanwpc.2025.101684_bib150","first-page":"309","article-title":"RNM-01 weight stability is associated with longer survival in amyotrophic lateral sclerosis","volume":"20","author":"Wei","year":"2019","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"10.1016\/j.lanwpc.2025.101684_bib151","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuro.2016.06.015","article-title":"Identification of risk factors associated with onset and progression of amyotrophic lateral sclerosis using systematic review and meta-analysis","volume":"61","author":"Wang","year":"2017","journal-title":"Neurotoxicology"},{"issue":"6","key":"10.1016\/j.lanwpc.2025.101684_bib152","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1007\/s00415-019-09276-2","article-title":"Prognostic significance of body weight variation after diagnosis in ALS: a single-centre prospective cohort study","volume":"266","author":"Shimizu","year":"2019","journal-title":"J Neurol"},{"key":"10.1016\/j.lanwpc.2025.101684_bib153","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1286153","article-title":"Ideal body weight-based determination of minimum oral calories beneficial to function and survival in ALS","volume":"14","author":"Nakamura","year":"2023","journal-title":"Front Neurol"},{"issue":"3","key":"10.1016\/j.lanwpc.2025.101684_bib154","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/ajcn\/74.3.328","article-title":"Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis","volume":"74","author":"Desport","year":"2001","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"10.1016\/j.lanwpc.2025.101684_bib155","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3945\/ajcn.113.069997","article-title":"Estimating daily energy expenditure in individuals with amyotrophic lateral sclerosis","volume":"99","author":"Kasarskis","year":"2014","journal-title":"Am J Clin Nutr"},{"issue":"1\u20132","key":"10.1016\/j.lanwpc.2025.101684_bib156","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/21678421.2016.1245756","article-title":"The measurement and estimation of total energy expenditure in Japanese patients with ALS: a doubly labelled water method study","volume":"18","author":"Shimizu","year":"2017","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"1","key":"10.1016\/j.lanwpc.2025.101684_bib157","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-97196-5","article-title":"Prognostic prediction by hypermetabolism varies depending on the nutritional status in early amyotrophic lateral sclerosis","volume":"11","author":"Nakamura","year":"2021","journal-title":"Sci Rep"},{"issue":"3\u20134","key":"10.1016\/j.lanwpc.2025.101684_bib158","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/21678421.2021.1946089","article-title":"Percutaneous gastrostomy in amyotrophic lateral sclerosis: a review","volume":"23","author":"Castanheira","year":"2022","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"11","key":"10.1016\/j.lanwpc.2025.101684_bib159","first-page":"7842","article-title":"Effect of complete high-caloric nutrition on the nutritional status and survival rate of amyotrophic lateral sclerosis patients after gastrostomy","volume":"14","author":"Wang","year":"2022","journal-title":"Am J Transl Res"},{"issue":"2","key":"10.1016\/j.lanwpc.2025.101684_bib160","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ana.25661","article-title":"Effect of high-caloric nutrition on survival in amyotrophic lateral sclerosis","volume":"87","author":"Ludolph","year":"2020","journal-title":"Ann Neurol"},{"issue":"9","key":"10.1016\/j.lanwpc.2025.101684_bib161","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1136\/jnnp-2020-323372","article-title":"Effect of high-caloric nutrition on serum neurofilament light chain levels in amyotrophic lateral sclerosis","volume":"91","author":"Dorst","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.lanwpc.2025.101684_bib162","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1136\/jnnp-2021-328331","article-title":"Fat-rich versus carbohydrate-rich nutrition in ALS: a randomised controlled study","volume":"93","author":"Dorst","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9934","key":"10.1016\/j.lanwpc.2025.101684_bib163","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/S0140-6736(14)60222-1","article-title":"Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial","volume":"383","author":"Wills","year":"2014","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.lanwpc.2025.101684_bib164","first-page":"255","article-title":"[Energy metabolism of ALS patients under mechanical ventilation and tube feeding]","volume":"31","author":"Shimizu","year":"1991","journal-title":"Rinsho Shinkeigaku"},{"issue":"6","key":"10.1016\/j.lanwpc.2025.101684_bib165","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3109\/17482968.2012.699968","article-title":"Energy requirement assessed by doubly-labeled water method in patients with advanced amyotrophic lateral sclerosis managed by tracheotomy positive pressure ventilation","volume":"13","author":"Ichihara","year":"2012","journal-title":"Amyotroph Lateral Scler"},{"issue":"1","key":"10.1016\/j.lanwpc.2025.101684_bib166","doi-asserted-by":"crossref","first-page":"7103","DOI":"10.1038\/s41598-024-56752-5","article-title":"Timing and impact of percutaneous endoscopic gastrostomy insertion in patients with amyotrophic lateral sclerosis: a comprehensive analysis","volume":"14","author":"Son","year":"2024","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.lanwpc.2025.101684_bib167","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.4187\/respcare.05031","article-title":"Use of noninvasive ventilation during feeding tube placement","volume":"62","author":"Banfi","year":"2017","journal-title":"Respir Care"},{"issue":"5","key":"10.1016\/j.lanwpc.2025.101684_bib168","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.3390\/toxins5051010","article-title":"Sialorrhea: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins","volume":"5","author":"Lakraj","year":"2013","journal-title":"Toxins (Basel)"},{"issue":"8","key":"10.1016\/j.lanwpc.2025.101684_bib169","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/sj.bdj.2013.421","article-title":"Saliva and oral health, 4th edition","volume":"214","author":"Hunter","year":"2013","journal-title":"Br Dent J"},{"issue":"4","key":"10.1016\/j.lanwpc.2025.101684_bib170","doi-asserted-by":"crossref","first-page":"e387","DOI":"10.1016\/j.jpainsymman.2021.12.005","article-title":"Prevalence of Sialorrhea among amyotrophic lateral sclerosis patients: a systematic review and meta-analysis","volume":"63","author":"Wang","year":"2022","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.lanwpc.2025.101684_bib171","first-page":"19","article-title":"Sialorrhea in patients with ALS: current treatment options","volume":"9","author":"Garuti","year":"2019","journal-title":"Degener Neurol Neuromuscul Dis"},{"key":"10.1016\/j.lanwpc.2025.101684_bib172","doi-asserted-by":"crossref","DOI":"10.1177\/1756286419888601","article-title":"The burden of sialorrhoea in chronic neurological conditions: current treatment options and the role of incobotulinumtoxinA (Xeomin\u00ae)","volume":"12","author":"Morgante","year":"2019","journal-title":"Ther Adv Neurol Disord"},{"issue":"3","key":"10.1016\/j.lanwpc.2025.101684_bib173","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/thoraxjnl-2016-208919","article-title":"Progress in respiratory management of bulbar complications of motor neuron disease\/amyotrophic lateral sclerosis?","volume":"72","author":"Simonds","year":"2017","journal-title":"Thorax"},{"issue":"11","key":"10.1016\/j.lanwpc.2025.101684_bib174","first-page":"2628","article-title":"Sialorrhea: a management challenge","volume":"69","author":"Hockstein","year":"2004","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.lanwpc.2025.101684_bib175","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1600-0404.2008.01037.x","article-title":"Treatment of sialorrhea in amyotrophic lateral sclerosis","volume":"188","author":"Tysnes","year":"2008","journal-title":"Acta Neurol Scand Suppl"},{"issue":"5","key":"10.1016\/j.lanwpc.2025.101684_bib176","article-title":"Treatment for sialorrhea (excessive saliva) in people with motor neuron disease\/amyotrophic lateral sclerosis","volume":"5","author":"James","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.lanwpc.2025.101684_bib177","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/mds.23473","article-title":"Botulinum toxin A versus B in sialorrhea: a prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease","volume":"26","author":"Guidubaldi","year":"2011","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.lanwpc.2025.101684_bib178","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/mus.21213","article-title":"Randomized double-blind study of botulinum toxin type B for sialorrhea in ALS patients","volume":"39","author":"Jackson","year":"2009","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.lanwpc.2025.101684_bib179","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/ane.12559","article-title":"Botulinum toxin-A injections vs radiotherapy for drooling in ALS","volume":"134","author":"Weikamp","year":"2016","journal-title":"Acta Neurol Scand"},{"issue":"1\u20132","key":"10.1016\/j.lanwpc.2025.101684_bib180","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jns.2015.02.008","article-title":"Managing excessive saliva with salivary gland irradiation in patients with amyotrophic lateral sclerosis","volume":"352","author":"Slade","year":"2015","journal-title":"J Neurol Sci"},{"issue":"1","key":"10.1016\/j.lanwpc.2025.101684_bib181","article-title":"Efficacy of non-pharmacological interventions for individuals with amyotrophic lateral sclerosis: systematic review and network meta-analysis of randomized control trials","volume":"14","author":"Li","year":"2024","journal-title":"Sci Rep"},{"issue":"1\u20132","key":"10.1016\/j.lanwpc.2025.101684_bib182","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0022-510X(01)00610-4","article-title":"The value of muscle exercise in patients with amyotrophic lateral sclerosis","volume":"191","author":"Drory","year":"2001","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.lanwpc.2025.101684_bib183","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.physio.2021.04.005","article-title":"Aerobic, resistance and combined exercise training for patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"113","author":"Rahmati","year":"2021","journal-title":"Physiotherapy"},{"issue":"2","key":"10.1016\/j.lanwpc.2025.101684_bib184","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41582-020-00434-z","article-title":"Improving clinical trial outcomes in amyotrophic lateral sclerosis","volume":"17","author":"Kiernan","year":"2021","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"10.1016\/j.lanwpc.2025.101684_bib185","first-page":"Cd004157","article-title":"Treatment for cramps in amyotrophic lateral sclerosis\/motor neuron disease","volume":"2012","author":"Baldinger","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.lanwpc.2025.101684_bib186","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2009.200642","article-title":"Tetrahydrocannabinol (THC) for cramps in amyotrophic lateral sclerosis: a randomised, double-blind crossover trial","volume":"81","author":"Weber","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.lanwpc.2025.101684_bib187","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/mus.27146","article-title":"Effects of mexiletine on hyperexcitability in sporadic amyotrophic lateral sclerosis: preliminary findings from a small phase II randomized controlled trial","volume":"63","author":"Weiss","year":"2021","journal-title":"Muscle Nerve"},{"issue":"16","key":"10.1016\/j.lanwpc.2025.101684_bib188","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1212\/WNL.0000000000002507","article-title":"A randomized trial of mexiletine in ALS: safety and effects on muscle cramps and progression","volume":"86","author":"Weiss","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.lanwpc.2025.101684_bib189","doi-asserted-by":"crossref","DOI":"10.1002\/mus.26117","article-title":"Mexiletine for muscle cramps in amyotrophic lateral sclerosis: a randomized, double-blind crossover trial","author":"Oskarsson","year":"2018","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.lanwpc.2025.101684_bib190","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/mus.20900","article-title":"Intrathecal baclofen for spasticity-related pain in amyotrophic lateral sclerosis: efficacy and factors associated with pain relief","volume":"37","author":"McClelland","year":"2008","journal-title":"Muscle Nerve"},{"issue":"7","key":"10.1016\/j.lanwpc.2025.101684_bib191","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3390\/toxins11070381","article-title":"Botulinum toxin type A and physiotherapy in spasticity of the lower limbs due to amyotrophic lateral sclerosis","volume":"11","author":"Marvulli","year":"2019","journal-title":"Toxins (Basel)"},{"issue":"2","key":"10.1016\/j.lanwpc.2025.101684_bib192","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1474-4422(18)30406-X","article-title":"Safety and efficacy of nabiximols on spasticity symptoms in patients with motor neuron disease (CANALS): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial","volume":"18","author":"Riva","year":"2019","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.lanwpc.2025.101684_bib193","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0300671","article-title":"Current perspectives on neuromodulation in ALS patients: a systematic review and meta-analysis","volume":"19","author":"Jim\u00e9nez-Garc\u00eda","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.lanwpc.2025.101684_bib194","first-page":"483","article-title":"Pseudobulbar affect: prevalence and management","volume":"9","author":"Ahmed","year":"2013","journal-title":"Ther Clin Risk Manag"},{"issue":"1","key":"10.1016\/j.lanwpc.2025.101684_bib195","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/jnnp.63.1.89","article-title":"A self report measure of affective lability","volume":"63","author":"Moore","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lanwpc.2025.101684_bib196","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jocn.2022.04.009","article-title":"Pseudobulbar affect in neurodegenerative diseases: a systematic review and meta-analysis","volume":"100","author":"Nabizadeh","year":"2022","journal-title":"J Clin Neurosci"},{"issue":"7","key":"10.1016\/j.lanwpc.2025.101684_bib197","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1586\/ern.11.68","article-title":"Pseudobulbar affect: the spectrum of clinical presentations, etiologies and treatments","volume":"11","author":"Miller","year":"2011","journal-title":"Expert Rev Neurother"},{"issue":"5","key":"10.1016\/j.lanwpc.2025.101684_bib198","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/ana.22093","article-title":"Dextromethorphan plus ultra low-dose quinidine reduces pseudobulbar affect","volume":"68","author":"Pioro","year":"2010","journal-title":"Ann Neurol"},{"issue":"8","key":"10.1016\/j.lanwpc.2025.101684_bib199","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1212\/01.WNL.0000142042.50528.2F","article-title":"Treatment of pseudobulbar affect in ALS with dextromethorphan\/quinidine: a randomized trial","volume":"63","author":"Brooks","year":"2004","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.lanwpc.2025.101684_bib200","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/s13311-016-0508-5","article-title":"Enhanced bulbar function in amyotrophic lateral sclerosis: the nuedexta treatment trial","volume":"14","author":"Smith","year":"2017","journal-title":"Neurotherapeutics"},{"issue":"1\u20132","key":"10.1016\/j.lanwpc.2025.101684_bib201","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neurol.2017.11.009","article-title":"Clinical features of pain in amyotrophic lateral sclerosis: a clinical challenge","volume":"175","author":"Delpont","year":"2019","journal-title":"Rev Neurol (Paris)"},{"issue":"7\u20138","key":"10.1016\/j.lanwpc.2025.101684_bib202","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/21678421.2021.1892765","article-title":"Prevalence of pain in amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"22","author":"Hurwitz","year":"2021","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"15","key":"10.1016\/j.lanwpc.2025.101684_bib203","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1080\/09638288.2018.1555615","article-title":"The multiple faces of pain in motor neuron disease: a qualitative study to inform pain assessment and pain management","volume":"42","author":"\u00c5kerblom","year":"2020","journal-title":"Disabil Rehabil"},{"issue":"2","key":"10.1016\/j.lanwpc.2025.101684_bib204","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/0825859719895827","article-title":"Engaging specialist palliative care in the management of amyotrophic lateral sclerosis: a Patient-, Family-, and provider-based approach","volume":"37","author":"Washington","year":"2022","journal-title":"J Palliat Care"},{"issue":"10","key":"10.1016\/j.lanwpc.2025.101684_bib205","doi-asserted-by":"crossref","first-page":"515","DOI":"10.62438\/tunismed.v102i10.5154","article-title":"Incidence and risk factors of venous thromboembolism in patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"102","author":"Hamad","year":"2024","journal-title":"Tunis Med"},{"issue":"11","key":"10.1016\/j.lanwpc.2025.101684_bib206","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/j.1468-1331.2008.02307.x","article-title":"Causes of death amongst French patients with amyotrophic lateral sclerosis: a prospective study","volume":"15","author":"Gil","year":"2008","journal-title":"Eur J Neurol"},{"issue":"3\u20134","key":"10.1016\/j.lanwpc.2025.101684_bib207","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3109\/21678421.2014.984724","article-title":"Venous thromboembolism in amyotrophic lateral sclerosis: should we consider routine prophylactic anticoagulation?","volume":"16","author":"Forrest","year":"2015","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"15","key":"10.1016\/j.lanwpc.2025.101684_bib208","doi-asserted-by":"crossref","first-page":"e1370","DOI":"10.1212\/WNL.0000000000006317","article-title":"ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS","volume":"91","author":"Crockford","year":"2018","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.lanwpc.2025.101684_bib209","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1136\/jnnp-2020-322992","article-title":"Progression of cognitive and behavioural impairment in early amyotrophic lateral sclerosis","volume":"91","author":"Beeldman","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10047","key":"10.1016\/j.lanwpc.2025.101684_bib210","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(16)00737-6","article-title":"The frontotemporal dementia-motor neuron disease continuum","volume":"388","author":"Burrell","year":"2016","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.lanwpc.2025.101684_bib211","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/WCO.0000000000000862","article-title":"Cognitive and behavioural impairment in amyotrophic lateral sclerosis","volume":"33","author":"Pender","year":"2020","journal-title":"Curr Opin Neurol"},{"issue":"1\u20132","key":"10.1016\/j.lanwpc.2025.101684_bib212","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/21678421.2022.2053721","article-title":"Apathy in amyotrophic lateral sclerosis: systematic review and meta-analysis of frequency, correlates, and outcomes","volume":"24","author":"Kutlubaev","year":"2023","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"14","key":"10.1016\/j.lanwpc.2025.101684_bib213","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1212\/WNL.0b013e318214359f","article-title":"Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia","volume":"76","author":"Elamin","year":"2011","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.lanwpc.2025.101684_bib214","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1017\/S1478951514000881","article-title":"A longer diagnostic interval is a risk for depression in amyotrophic lateral sclerosis","volume":"13","author":"Caga","year":"2015","journal-title":"Palliat Support Care"},{"issue":"1","key":"10.1016\/j.lanwpc.2025.101684_bib215","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/mus.25712","article-title":"Improving symptom management for people with amyotrophic lateral sclerosis","volume":"57","author":"Nicholson","year":"2018","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.lanwpc.2025.101684_bib216","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1136\/bmjspcare.2010.232637.rep","article-title":"Palliative care in amyotrophic lateral sclerosis: a review of current international guidelines and initiatives","volume":"1","author":"Bede","year":"2011","journal-title":"BMJ Support Palliat Care"},{"issue":"1","key":"10.1016\/j.lanwpc.2025.101684_bib217","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/bmjspcare-2013-000588","article-title":"Palliative care development in the Asia-Pacific region: an international survey from the Asia Pacific Hospice Palliative Care Network (APHN)","volume":"7","author":"Yamaguchi","year":"2017","journal-title":"BMJ Support Palliat Care"},{"issue":"1","key":"10.1016\/j.lanwpc.2025.101684_bib218","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/0269216307084609","article-title":"Survey of specialist palliative care services for noncancer patients in Ireland and perceived barriers","volume":"22","author":"O'Leary","year":"2008","journal-title":"Palliat Med"},{"issue":"6","key":"10.1016\/j.lanwpc.2025.101684_bib219","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1177\/0269216311416036","article-title":"Motor Neurone disease family carers' experiences of caring, palliative care and bereavement: an exploratory qualitative study","volume":"26","author":"Aoun","year":"2012","journal-title":"Palliat Med"},{"issue":"1","key":"10.1016\/j.lanwpc.2025.101684_bib220","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12904-016-0153-0","article-title":"Caregiving in ALS - a mixed methods approach to the study of burden","volume":"15","author":"Galvin","year":"2016","journal-title":"BMC Palliat Care"},{"issue":"5\u20136","key":"10.1016\/j.lanwpc.2025.101684_bib221","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3109\/17482960802459889","article-title":"How common is depression among ALS caregivers? A longitudinal study","volume":"10","author":"Rabkin","year":"2009","journal-title":"Amyotroph Lateral Scler"},{"key":"10.1016\/j.lanwpc.2025.101684_bib222","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev-psych-010419-050754","article-title":"Family caregiving for older adults","volume":"71","author":"Schulz","year":"2020","journal-title":"Annu Rev Psychol"},{"issue":"11","key":"10.1016\/j.lanwpc.2025.101684_bib223","first-page":"699","article-title":"Caregiver care","volume":"99","author":"Swartz","year":"2019","journal-title":"Am Fam Physician"},{"issue":"10","key":"10.1016\/j.lanwpc.2025.101684_bib224","doi-asserted-by":"crossref","first-page":"593","DOI":"10.11622\/smedj.2021033","article-title":"Caregiver burden and its prevalence, measurement scales, predictive factors and impact: a review with an Asian perspective","volume":"63","author":"Loo","year":"2022","journal-title":"Singapore Med J"},{"issue":"2","key":"10.1016\/j.lanwpc.2025.101684_bib225","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/17482968.2010.546414","article-title":"From symptom onset to a diagnosis of amyotrophic lateral sclerosis\/motor neuron disease (ALS\/MND): experiences of people with ALS\/MND and family carers - a qualitative study","volume":"12","author":"O'Brien","year":"2011","journal-title":"Amyotroph Lateral Scler"},{"issue":"5","key":"10.1016\/j.lanwpc.2025.101684_bib226","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s11136-010-9804-4","article-title":"Predictors of quality of life in carers for people with a progressive neurological illness: a longitudinal study","volume":"20","author":"O'Connor","year":"2011","journal-title":"Qual Life Res"},{"issue":"6","key":"10.1016\/j.lanwpc.2025.101684_bib227","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1017\/S0033291706007124","article-title":"Predictors of psychological distress in carers of people with amyotrophic lateral sclerosis: a longitudinal study","volume":"36","author":"Goldstein","year":"2006","journal-title":"Psychol Med"},{"issue":"4","key":"10.1016\/j.lanwpc.2025.101684_bib228","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0885-3924(03)00323-3","article-title":"Quality of life and psychosocial issues in ventilated patients with amyotrophic lateral sclerosis and their caregivers","volume":"26","author":"Kaub-Wittemer","year":"2003","journal-title":"J Pain Symptom Manage"},{"issue":"1\u20132","key":"10.1016\/j.lanwpc.2025.101684_bib229","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0022-510X(03)00003-0","article-title":"A study comparing patients with amyotrophic lateral sclerosis and their caregivers on measures of quality of life, depression, and their attitudes toward treatment options","volume":"209","author":"Trail","year":"2003","journal-title":"J Neurol Sci"},{"issue":"1","key":"10.1016\/j.lanwpc.2025.101684_bib230","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/237437431500200103","article-title":"Who is taking care of the caregiver?","volume":"2","author":"Sullivan","year":"2015","journal-title":"J Patient Exp"},{"issue":"1","key":"10.1016\/j.lanwpc.2025.101684_bib231","first-page":"1","article-title":"Caregivers of ALS patients: their experiences and needs","volume":"17","author":"Yang","year":"2024"},{"issue":"1","key":"10.1016\/j.lanwpc.2025.101684_bib232","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/0269216317709965","article-title":"Caregiver burden in amyotrophic lateral sclerosis: a systematic review","volume":"32","author":"de Wit","year":"2018","journal-title":"Palliat Med"},{"issue":"7\u20138","key":"10.1016\/j.lanwpc.2025.101684_bib233","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/21678421.2020.1771735","article-title":"Differentiating needs of informal caregivers of individuals with ALS across the caregiving course: a systematic review","volume":"21","author":"Poppe","year":"2020","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"4","key":"10.1016\/j.lanwpc.2025.101684_bib234","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ijop.12085","article-title":"The family experience of living with a person with amyotrophic lateral sclerosis: a qualitative study","volume":"50","author":"Cipolletta","year":"2015","journal-title":"Int J Psychol"},{"issue":"1","key":"10.1016\/j.lanwpc.2025.101684_bib235","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0733-8619(18)30936-8","article-title":"The family support group in the treatment of amyotrophic lateral sclerosis","volume":"5","author":"Finger","year":"1987","journal-title":"Neurol Clin"},{"issue":"2","key":"10.1016\/j.lanwpc.2025.101684_bib236","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1001\/jama.298.2.207","article-title":"Palliative care for patients with amyotrophic lateral sclerosis: \"prepare for the worst and hope for the best\"","volume":"298","author":"Mitsumoto","year":"2007","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.lanwpc.2025.101684_bib237","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s00415-017-8448-5","article-title":"Caregivers of patients with amyotrophic lateral sclerosis: investigating quality of life, caregiver burden, service engagement, and patient survival","volume":"264","author":"Burke","year":"2017","journal-title":"J Neurol"},{"issue":"2","key":"10.1016\/j.lanwpc.2025.101684_bib238","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1474-4422(24)00523-4","article-title":"Transforming amyotrophic lateral sclerosis into a liveable disease","volume":"24","author":"Feldman","year":"2025","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.lanwpc.2025.101684_bib239","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16532","article-title":"Amyotrophic lateral sclerosis established as a multistep process across phenotypes","volume":"32","author":"Ziser","year":"2025","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.lanwpc.2025.101684_bib240","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/mus.28290","article-title":"Amyotrophic lateral sclerosis represents corticomotoneuronal system failure","volume":"71","author":"Eisen","year":"2024","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.lanwpc.2025.101684_bib241","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s40478-023-01670-2","article-title":"Heterogeneity of cortical pTDP-43 inclusion morphologies in amyotrophic lateral sclerosis","volume":"11","author":"Tan","year":"2023","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"10.1016\/j.lanwpc.2025.101684_bib242","doi-asserted-by":"crossref","DOI":"10.1111\/nan.12944","article-title":"The importance of patient-centred drug development for amyotrophic lateral sclerosis","volume":"49","author":"Kiernan","year":"2023","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"7","key":"10.1016\/j.lanwpc.2025.101684_bib243","doi-asserted-by":"crossref","DOI":"10.1111\/nan.12845","article-title":"The contribution of brain banks to knowledge discovery in amyotrophic lateral sclerosis: a systematic review","volume":"48","author":"Mazumder","year":"2022","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.lanwpc.2025.101684_bib244","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1474-4422(05)70042-9","article-title":"Assessment of disease progression in motor neuron disease","volume":"4","author":"Winhammar","year":"2005","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.lanwpc.2025.101684_bib245","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S1474-4422(23)00043-1","article-title":"A spirited community that knows how to fight","volume":"22","author":"Morgan","year":"2023","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.lanwpc.2025.101684_bib246","article-title":"Risk factors for the neurodegenerative dementias in the Western Pacific region","volume":"50","author":"Clarke","year":"2024","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.lanwpc.2025.101684_bib247","article-title":"A scoping review of the unique landscape and challenges associated with dementia in the Western Pacific region","volume":"50","author":"Devenney","year":"2024","journal-title":"Lancet Reg Health West Pac"},{"issue":"9","key":"10.1016\/j.lanwpc.2025.101684_bib248","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1080\/13543784.2023.2263368","article-title":"Nanocrystalline gold (CNM-Au8): a novel bioenergetic treatment for ALS","volume":"32","author":"Vucic","year":"2023","journal-title":"Expert Opin Investig Drugs"}],"container-title":["The Lancet Regional Health - Western Pacific"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606525002238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606525002238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T21:37:46Z","timestamp":1764884266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666606525002238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":248,"alternative-id":["S2666606525002238"],"URL":"https:\/\/doi.org\/10.1016\/j.lanwpc.2025.101684","relation":{},"ISSN":["2666-6065"],"issn-type":[{"value":"2666-6065","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pan-Asian consortium for treatment and research in ALS (PACTALS) guidelines for management of amyotrophic lateral sclerosis","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Western Pacific","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanwpc.2025.101684","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101684"}}